Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies.

scientific article published on 27 December 2016

Personalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3389/FPHYS.2016.00644
P932PMC publication ID5186797
P698PubMed publication ID28082911

P50authorChristian DienerQ41044712
Osbaldo ResendisQ55860492
P2093author name stringChristian Diener
Osbaldo Resendis-Antonio
P2860cites workGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesQ24536351
NCBI GEO: archive for functional genomics data sets--updateQ24595691
Comprehensive molecular portraits of human breast tumoursQ24630844
Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisionsQ26261171
Modeling metabolism: a window toward a comprehensive interpretation of networks in cancerQ27021633
Comprehensive molecular characterization of clear cell renal cell carcinomaQ27852374
The BioMart community portal: an innovative alternative to large, centralized data repositoriesQ27949361
Metabolic pathways promoting cancer cell survival and growthQ28086940
What is flux balance analysis?Q28275348
Energy metabolism in tumor cellsQ28288377
Reconstruction of Tissue-Specific Metabolic Networks Using CORDAQ28388815
Context-specific metabolic networks are consistent with experimentsQ28472711
Reconstruction of genome-scale active metabolic networks for 69 human cell types and 16 cancer types using INITQ28483779
Systematic evaluation of methods for integration of transcriptomic data into constraint-based models of metabolismQ28538197
Exon array analyses across the NCI-60 reveal potential regulation of TOP1 by transcription pausing at guanosine quartets in the first intronQ28749651
PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesQ29547229
Regularization Paths for Generalized Linear Models via Coordinate DescentQ29614491
The NCI60 human tumour cell line anticancer drug screenQ29614975
The causes and consequences of genetic heterogeneity in cancer evolutionQ29615848
Oxidative stress, inflammation, and cancer: how are they linked?Q29616835
A gene expression database for the molecular pharmacology of cancerQ29619242
Predicting cellular growth from gene expression signaturesQ33396962
Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modelingQ33597307
Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale modelsQ33642720
Modeling core metabolism in cancer cells: surveying the topology underlying the Warburg effectQ33682181
Computationally efficient flux variability analysisQ33709846
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of originQ34123261
A framework for oligonucleotide microarray preprocessing.Q34149103
Fructose-1,6-bisphosphatase opposes renal carcinoma progressionQ34173576
Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma developmentQ34315320
Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinomaQ34405226
Reconstruction of genome-scale metabolic models for 126 human tissues using mCADREQ34509501
Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancerQ34545824
Comprehensive Pan-Genomic Characterization of Adrenocortical CarcinomaQ34677263
COBRApy: COnstraints-Based Reconstruction and Analysis for PythonQ34911268
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancerQ35587470
Human metabolic atlas: an online resource for human metabolismQ35713056
Modeling cancer metabolism on a genome scaleQ35850350
Metabolic Heterogeneity in Human Lung Tumors.Q36578111
Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolismQ36852748
Intratumoral Heterogeneity of the Epigenome.Q36854908
Heterogeneity of tumor-induced gene expression changes in the human metabolic networkQ36927094
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancerQ36967938
TAp73 enhances the pentose phosphate pathway and supports cell proliferationQ37071124
Cellular fatty acid metabolism and cancerQ37092913
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seqQ37094024
Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneityQ37094872
Cancer metabolism: fatty acid oxidation in the limelightQ37155867
The complex role of branched chain amino acids in diabetes and cancerQ37608822
Oxidative stress and cancer: an overviewQ38057533
The pentose phosphate pathway and cancerQ38231069
Personalized Whole-Cell Kinetic Models of Metabolism for Discovery in Genomics and PharmacodynamicsQ39803501
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity.Q40139573
BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladderQ40738932
Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.Q41086451
Metabolic Remodeling in Times of Stress: Who Shoots Faster than His Shadow?Q52922856
P921main subjectbiopsyQ179991
P304page(s)644
P577publication date2016-12-27
P1433published inFrontiers in PhysiologyQ2434141
P1476titlePersonalized Prediction of Proliferation Rates and Metabolic Liabilities in Cancer Biopsies
P478volume7